Camilla Sylvest joined Novo Nordisk in 1996 as trainee. From 1997 to 2008 Ms Sylvest had roles in headquarters and regions within pricing, health economics, marketing and sales effectiveness. In 2003, she was appointed vice president of sales and marketing effectiveness in Region Europe. From 2008 to 2015, Ms Sylvest headed up affiliates and business areas of growing size and complexity in Europe and Asia and in 2013 she was also appointed corporate vice president. In August 2015, Ms Sylvest was appointed senior vice president and general manager of Novo Nordisk’s Region China. In this role she was responsible for the company’s activities in China, Taiwan and Hong Kong. In October 2017, Ms Sylvest was promoted to executive vice president.
Ms Sylvest serves as member of the board of Danish Crown A/S, Denmark.
Ms Sylvest holds an MSc in Economics from University of Southern Denmark and an Executive MBA from Scandinavian International Management Institute.
Ms Sylvest is a Danish national, born November 1972.
Un llamado a los líderes empresariales para innovar y crear lugares de trabajo que promuevan la salud, previniendo la obesidad y apoyando a quienes viven con ella.
Business leaders can innovate and create health-promoting workplaces – and consequently, support employees with obesity prevention measures.
Obesity is a global problem associated with multiple medical conditions and tackling it effectively requires local and global multi-sector collaborations.
Patients affected by obesity need access to "patient-friendly" healthcare and expertise to tackle global epidemic.
All of us - companies, politicians and consumers – must contribute to solving climate change. Yet it is easy to be overwhelmed by the task at hand. Where do I start? Here's how one multi...
